HEADLINES

Cancer News

A NEW WAVE OF MEDICINE: ANSWER THE CALL

The ocean is calling and beneath its surface dwells an unseen power to heal. Dr. Hendrik Luesch explores the world’s oceans in search of natural compounds that treat cancer and other deadly diseases. In these uncharted waters, lies new chemistry, new biology and new cures just waiting to be revealed. His discoveries have already provided the basis for various FDA-approved cancer treatments and new starting points to treat pancreatic, colon, breast and ovarian cancers, as well as ocular and autoimmune diseases. He is also working on the development of broad-spectrum antivirals to combat COVID-19 and future pandemics.

  Play Video

DRIVING EQUITY & INCLUSION IN CANCER CARE: A Q&A WITH DR. RAYMOND MAILHOT

Raymond Mailhot, M.D., dedicates his research to improving radiation treatment. He cares for pediatric patients and patients with breast cancer, and he leads the hematology malignancy radiotherapy program. In this Q&A, Dr. Mailhot shares how he’s working to accelerate equity in cancer care and reflects on personal experiences with structural racism in oncology.

RM

SCOPE OF TREATMENT SEQUENCING GROWS IN GENITOURINARY MALIGNANCIES

Checkpoint inhibitors have become staples of frontline and maintenance treatment for patients with metastatic renal cell carcinoma (mRCC) and advanced urothelial cancer, respectively, said Jonathan A. Chatzkel, MD, who added that the initial excitement seen with immunotherapy in those settings is now being seen with the second- and third-line use of antibody-drug conjugates (ADCs) and FGFR inhibitors in urothelial cancer.

j